BD HPV Assay Receives WHO Prequalification for Global Cervical Cancer Screening
The BD Onclarity HPV Assay detects 14 high-risk HPV types and supports self-collection.
Read MorePosted by CLP Edit Staff | Nov 17, 2025 | Cervical (HPV) |
The BD Onclarity HPV Assay detects 14 high-risk HPV types and supports self-collection.
Read MorePosted by Alyx Arnett | Nov 13, 2025 | Lab Equipment |
Even as automation accelerates, hands-on micromanipulation remains essential for precision tasks, exploratory research, and applications where human judgment outperforms algorithms.
Read MorePosted by CLP Edit Staff | Nov 12, 2025 | Molecular Diagnostics |
The collaboration combines SOPHiA’s DDM platform with Element’s AVITI sequencing systems to streamline genomic workflows for precision medicine research.
Read MorePosted by CLP Edit Staff | Nov 12, 2025 | Mass Spectrometry Instruments |
The system combines enhanced sensitivity with automation to detect M-proteins at low concentrations, supporting early diagnosis of plasma cell disorders.
Read MorePosted by CLP Edit Staff | Nov 10, 2025 | Cancer |
A simulation model shows that annual liquid biopsy screening would increase early-stage cancer detection by up to 30% while cutting stage IV diagnoses by 45%.
Read More